Comirnaty
COVID-19 mRNA vaccine
tozinameran
riltozinameran and tozinameran
famtozinameran and tozinameran
raxtozinameran
COVID-19 virus infection
Date of authorisation:
Revision: 47
Last updated:
MedicineHumanAuthorised
Nuvaxovid
COVID-19 Vaccine (recombinant, adjuvanted)
COVID-19 virus infection
Date of authorisation:
Revision: 13
Last updated:
MedicineHumanAuthorised
Bimervax
COVID-19 Vaccine (recombinant, adjuvanted)
selvacovatein
COVID-19 virus infection
Date of authorisation:
Revision: 6
Last updated:
MedicineHumanAuthorised
Ronapreve
casirivimab
imdevimab
COVID-19 virus infection
Date of authorisation:
Revision: 7
Last updated:
MedicineHumanAuthorised
COVID-19 vaccines: key facts

The European Medicines Agency (EMA) continues to monitor the safety of vaccines against COVID-19 and to ensure that they offer protection in the European Union (EU), even though the public health emergency has ended. On this page you can find answers to key questions on the effectiveness and safety of COVID-19 vaccines in general, as well as on...

Last updated:
HumanCOVID-19
Public-health advice on COVID-19 medicines

Since the onset of the COVID-19 pandemic, the European Medicines Agency (EMA) has provided impartial advice to patients and healthcare professionals on the safe use of medicines, in particular in patients with or at risk of COVID-19 infection.

Last updated:
HumanCOVID-19
Xevudy
sotrovimab
COVID-19 virus infection
Date of authorisation:
Revision: 15
Last updated:
MedicineHumanAuthorised